Minerva Neurosciences (NERV) Intangibles (2013 - 2024)
Minerva Neurosciences posted quarterly Intangibles of $4257.0 for Q2 2024, down 85.71% year-on-year from $29797.0 in Q3 2023, and down 60.0% on a QoQ basis from $10642.0 in Q1 2024.
Minerva Neurosciences (NERV) has 12 years of Intangibles data on file, last reported at $4257.0 in Q2 2024.
- For the quarter ending Q2 2024, Intangibles fell 85.71% year-over-year to $4257.0; the trailing twelve-month figure through Jun 2024 stood at $4257.0 (down 85.71% YoY), and the FY2023 full-year result was $17027.0, down 60.0% from the prior year.
- Intangibles for Q2 2024 stood at $4257.0, down from $10642.0 in the prior quarter.
- Across five years, Intangibles topped out at $15.2 million in Q1 2020 and bottomed at $4257.0 in Q2 2024.
- The 5-year median for Intangibles is $51080.0 (2021), against an average of $5.9 million.
- The widest annual swing landed in 2020, when Intangibles changed 0.0%; it then sank 99.68% in 2022.
- A 5-year view of Intangibles shows it stood at $15.2 million in 2020, then sank by 99.66% to $51080.0 in 2021, then slipped by 16.67% to $42567.0 in 2022, then sank by 60.0% to $17027.0 in 2023, then plunged by 75.0% to $4257.0 in 2024.
- The last three Intangibles figures came in at $4257.0 (Q2 2024), $10642.0 (Q1 2024), and $17027.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4,257.00 |
| Mar 31, 2024 | 10,642.00 |
| Dec 31, 2023 | 17,027.00 |
| Sep 30, 2023 | 23,412.00 |
| Jun 30, 2023 | 29,797.00 |
| Mar 31, 2023 | 36,182.00 |
| Dec 31, 2022 | 42,567.00 |
| Sep 30, 2022 | 48,952.00 |
| Jun 30, 2022 | 51,080.00 |
| Mar 31, 2022 | 51,080.00 |
| Dec 31, 2021 | 51,080.00 |
| Sep 30, 2021 | 15.20 Mn |
| Jun 30, 2021 | 15.20 Mn |
| Mar 31, 2021 | 15.20 Mn |
| Dec 31, 2020 | 15.20 Mn |
| Sep 30, 2020 | 15.20 Mn |
| Jun 30, 2020 | 15.20 Mn |
| Mar 31, 2020 | 15.20 Mn |
| Dec 31, 2019 | 15.20 Mn |
| Sep 30, 2019 | 34.20 Mn |
| Jun 30, 2019 | 34.20 Mn |
| Mar 31, 2019 | 34.20 Mn |
| Dec 31, 2018 | 34.20 Mn |
| Sep 30, 2018 | 34.20 Mn |
| Jun 30, 2018 | 34.20 Mn |
| Mar 31, 2018 | 34.20 Mn |
| Dec 31, 2017 | 34.20 Mn |
| Sep 30, 2017 | 34.20 Mn |
| Jun 30, 2017 | 34.20 Mn |
| Mar 31, 2017 | 34.20 Mn |
| Dec 31, 2016 | 34.20 Mn |
| Sep 30, 2016 | 34.20 Mn |
| Jun 30, 2016 | 34.20 Mn |
| Mar 31, 2016 | 34.20 Mn |
| Dec 31, 2015 | 34.20 Mn |
| Sep 30, 2015 | 34.20 Mn |
| Jun 30, 2015 | 34.20 Mn |
| Mar 31, 2015 | 34.20 Mn |
| Dec 31, 2014 | 34.20 Mn |
| Sep 30, 2014 | 34.20 Mn |
| Jun 30, 2014 | 34.20 Mn |
| Dec 31, 2013 | 19.00 Mn |